Target intelligence / Profile preview

Long intergenic non-protein coding RNA 2560 (LINC02560)

Target
LINC02560
Molecular classification
Long non-coding RNA (lncRNA), Other
01

Overview

Long intergenic non-protein coding RNA 2560 (LINC02560) is a human long non-coding RNA located on chromosome 19 (Ensembl: ENSG00000268307, HGNC:53600). LINC02560 does not code for a protein, but exerts regulatory effects on gene expression and epigenetic processes. Elevated expression of LINC02560 has been observed in hepatocellular carcinoma and other cancer types, where it is involved in pathways promoting cell proliferation, migration, invasion, apoptosis resistance, cancer metabolism, immune evasion, and chemoresistance. LINC02560 acts by interacting with proteins like the transcription factor GLI2, modulating their stability, activity, and expression, sometimes by affecting epigenetic marks on target genes. Its aberrant expression correlates with disease progression and prognosis, highlighting potential utility as a prognostic biomarker, though it is not a classical therapeutic target such as a receptor or enzyme.

Other names
CTD-2619J13.13LINC02560
02

Mechanism of action

Regulation of transcription factors (e.g., GLI2); Modulation of signaling pathways (e.g., PI3K/Akt/mTOR, MAPK/ERK); Epigenetic modification (e.g., DNA methylation, histone modification); Regulation of competitive endogenous RNA (ceRNA) networks.

03

Biological functions

Regulation of gene expressionEpigenetic regulationCell proliferationCell invasionCell migrationApoptosisMetabolic regulationImmune escapeDrug resistance
04

Disease associations

Cancer (notably hepatocellular carcinoma, colorectal cancer, pan-cancer)Other (Ellis-van Creveld syndrome association; evidence in multiple cancer types)
05

Safety considerations

No documented safety or therapeutic risks; as a non-protein coding RNA, it is not itself a drug target. Targeting lncRNAs therapeutically may have challenges related to delivery and off-target effects, but specifics for LINC02560 are not reported.
06

Biomarkers

Prognostic marker for hepatocellular carcinomaPrognostic value in colorectal cancer

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 2560 (LINC02560).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 2560 (LINC02560).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call